Nearly two months after biotechnology company Monsanto rejected a $62 billion takeover offer from Bayer AG, the German pharmaceutical company said Thursday it has upped the proposal by about $3 billion. On July 1, Bayer offered shareholders of Missouri-based Monsanto $125 per stock share, which is $3 per share higher ... Read More »